Spire Healthcare Group (LON:SPI) Trading Up 38.3% – Still a Buy?

Spire Healthcare Group plc (LON:SPI)’s share price was up 38.3% on Thursday . The stock traded as high as GBX 215.50 and last traded at GBX 208.05. Approximately 52,664,664 shares were traded during mid-day trading, an increase of 1,295% from the average daily volume of 3,776,149 shares. The stock had previously closed at GBX 150.40.

Spire Healthcare Group Price Performance

The company has a current ratio of 0.63, a quick ratio of 0.74 and a debt-to-equity ratio of 177.14. The company’s fifty day moving average is GBX 163.07 and its two-hundred day moving average is GBX 185.65. The stock has a market cap of £889.33 million, a price-to-earnings ratio of 55.50, a P/E/G ratio of 1.06 and a beta of 0.91.

Spire Healthcare Group (LON:SPI) last posted its earnings results on Friday, March 6th. The company reported GBX 9.60 earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%. As a group, research analysts predict that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.